A novel liposomal delivery system utilizing milkfat globule membrane phospholipids to encapsulate bioactives, stable at pasteurization temperatures, ideal for beverages.
This innovative liposomal delivery system employs milkfat globule membrane phospholipids to create temperature-stable liposomes capable of encapsulating both lipophilic and hydrophilic bioactives. This system is uniquely suited for integration into beverages, offering a method to deliver bioactive compounds without the need for organic solvents, thereby maintaining the integrity and efficacy of the bioactives during pasteurization.
The technology has achieved a Technology Readiness Level of 6, indicating that it has been demonstrated in a relevant environment, with further demonstrations planned to showcase its efficacy and applications to potential partners.
Cornell University is a comprehensive private, land-grant research university with campuses in Ithaca and New York City, combining significant scale with cross-disciplinary breadth. Industry connects through open-access user facilities and prototyping labs, pilot-scale testbeds, and a research and technology park that provide pathways from discovery to demonstration. A statewide extension network and integration with a major hospital system enable real-world deployment, while a graduate campus embedded in New York City’s tech corridor provides direct access to startups, venture investors, and corporate R&D teams. Research is supported by competitive federal funding from agencies such as the National Science Foundation, National Institutes of Health, the Department of Energy, and the U.S. Department of Agriculture. A dedicated technology transfer office streamlines IP management, licensing, startup formation, and corporate partnerships across campuses.